The Europe generic injectables market was valued at USD 14.57 Billion in 2025, driven by the rising prevalence of chronic diseases and the increased strategic partnerships among the key market players in the region. The market is expected to grow at a CAGR of 7.90% during the forecast period of 2026-2035, with the values likely to rise from to USD 31.17 Billion by 2035.
Base Year
Historical Period
Forecast Period
Recent data suggests that 1 out of 3 adults in the European Union are reported to be affected by a chronic health problem. As a result, the demand for affordable healthcare solutions, including treatments for chronic conditions that often require injectable drugs, is poised to rise which will directly impact the market dynamics.
One of the major Europe generic injectables market trends is the increased strategic partnerships among the key market players to expand market reach and address the shortage of generic injectables in hospital settings.
The market share is influenced by the increased initiatives and policies by the government to encourage the use of cost-effective generic medications including generic injectables.
Compound Annual Growth Rate
7.9%
Value in USD Billion
2026-2035
*this image is indicative*
Generic injectables have the same active pharmaceutical ingredient as their brand-name injectables along with equivalent clinical performance, strength, and intended use. Unlike branded injectables, generic injectable drugs are lower in price and thus are an efficient means to manage healthcare costs. The rising expiration of market exclusivity of various brand-name injectables is contributing to the substantial expansion of the global generic injectables market. Further, the increased initiatives and policies by the government to encourage the use of affordable generic medications are fuelling the Europe generic injectables market demand.
The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases in the region along with the growing aging population that is more susceptible to developing a health condition is augmenting the demand for cost-effective medications such as generic injectables. Recent data suggests that 1 out of 3 adults in the European Union are reported to be affected by a chronic health problem, with an increasing proportion of chronically ill patients suffering from multi-morbidity. Additionally, older people are more prone to multiple morbidities, with the prevalence reported to be up to 65% and 85% in people aged above 65 and 85 years, respectively. As a result, the demand for healthcare services, including treatments for chronic conditions that often require injectable drugs is projected to rise. Consequently, the rising healthcare needs are estimated to propel the Europe generic injectables market growth.
Strategic partnerships among the key market players are one of the major market trends. In September 2023, Advanz Pharma Corp., a British multinational pharmaceutical company headquartered in London, signed an exclusive agreement with a Spanish biopharmaceutical firm GP Pharm to market and distribute its peptide specialty injectable generic intended for a rare disease in multiple European countries. Such collaborations and distribution agreements to expand market reach and enhance the accessibility of generic injectables are anticipated to bolster the market share in the forecast period.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Container Type
Market Breakup by Application
Market Breakup by Route of Administration
Market Breakup by Distribution Channel
Market Breakup by Region
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
The global pharmaceutical giant Pfizer has a strong presence in the market through strategic mergers and acquisitions. The company focuses on high-demand therapeutic areas like oncology and cardiovascular diseases and invests substantially in the development of new and improved generic injectables.
Headquartered in Israel, this company is a major market player and is involved in rigorous R&D initiatives aimed at expanding its generic product offerings.
Baxter is another key market player known for its range of generic injectables. The company focuses on ensuring high quality and safety standards in the manufacturing processes of injectables by integration of advanced technologies.
Novartis, via its spin-off Sandoz, is heavily involved in the generic injectables sector, especially in developing affordable and effective generic products that address drug shortages in critical care areas.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Viatris Inc., Biocon, Sanofi, Lupin, and Aurobindo Pharma Limited, among others.
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 14.57 Billion in 2025 driven by the rising healthcare needs in the region.
The market is anticipated to grow at a CAGR of 7.90% during the forecast period of 2026-2035, likely to reach a market value of USD 31.17 Billion by 2035.
The growing prevalence of chronic diseases and the presence of a supportive regulatory framework are fuelling the demand for the market.
One of the significant trends in the market is the increased strategic partnerships among the key market players. In September 2023, Advanz Pharma Corp., signed an exclusive agreement with GP Pharm to commercialize its peptide specialty injectable generic developed to treat a rare disease occuring in multiple European countries.
Based on the product type, the market is segmented into large molecule injectables and small molecule injectables. Large molecule injectables are further divided into monoclonal antibodies (mAbs), insulin, others.
Container types available in the market include vials, premix, prefilled syringes, and ampoules, among others.
Major applications of generic injectables include oncology, cardiovascular, CNS, infectious diseases, and autoimmune disorders, among others.
The market breakup by route of administration includes intravenous, intramuscular, and subcutaneous, among others.
Distribution channels of the market are hospitals and retail pharmacies, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, Novartis Pharmaceuticals Corporation, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Viatris Inc., Biocon, Sanofi, Lupin, and Aurobindo Pharma Limited.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Container Type |
|
| Breakup by Application |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share